Significant Collaboration Between Insilico Medicine and Eli Lilly
Insilico Medicine has announced a collaboration agreement with Eli Lilly worth <strong>$2.75 billion</strong> aimed at developing new drugs. This partnership comes at a time when the pharmaceutical industry is increasingly turning to modern technology for research and development.